AG Paxton secures a deal with Purdue Pharma for bankruptcy reorganization, creating Knoa Pharma and a Master Creditor Trust.

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...

Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge Robert ...

A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states, tribes, ...

STAMFORD, Conn.--(BUSINESS WIRE)--The United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”) today indicated it will approve the Chapter 11 Plan of ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

The Supreme Court blocked an earlier version of Purdue’s bankruptcy settlement. Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no ...

Purdue Pharma said Friday that the U.S. Bankruptcy Court for the Southern District of New York has indicated it intends to approve the company’s long-running Chapter 11 reorganization plan, a step ...